Cis-diamminedichloride platinum II (DDP) in the treatment of penile carcinoma.
Cis-diamminedichloride platinum II (DDP) was administered to eight patients with epidermoid carcinoma of the penis. Three of six adequately treated patients had an objective response: one patient achieved complete remission of 7 months duration and 2 patients had partial remissions of 8 and 2 months, respectively. DDP appears to be an active agent in the treatment of penile carcinoma.
D000328:Adult; D000368:Aged; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy*; D002945:Cisplatin / Q000627:therapeutic use*; D006801:Humans; D008207:Lymphatic Metastasis / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D010412:Penile Neoplasms / Q000188:drug therapy*; D012075:Remission, Spontaneous; D013997:Time Factors
D002945:Cisplatin